Although equilibrium radionuclide angiographic measurement of right ventricular ejection fraction (RVEF) has been validated in patients with coronary artery disease, the accuracy of this technique has not been demonstrated in patients with other cardiac diseases which may result in RV pressure and/or volume overload. The accuracy of three methods of equilibrium radionuclide analysis for measuring RVEF was compared in several subgroups of patients with a variety of cardiac diseases, including congenital and valvular heart disease, cor pulmonale, and cardiomyopathy. It was concluded that RVEF may be accurately derived by equilibrium radionuclide ventriculography in patients with a wide variety of cardiac diseases, including those resulting in RV volume and/or pressure overload. Accuracy varies depending on analysis method and the nature of the hemodynamic derangement.